O fator de impacto mede o número médio de citações recebidas em um ano por trabalhos publicados na revista durante os dois anos anteriores.
© Clarivate Analytics, Journal Citation Reports 2025
Informação da revista
Os mais lidos
29850
Cardiopulmonary exercise testing in clinical practice: Principles, applications, and basic interpretationHélder Dores, Miguel Mendes, Ana Abreu, Anaí Durazzo, Cidália Rodrigues, Eduardo Vilela, Gonçalo Cunha, José Gomes Pereira, ... Mário Santos
Rev Port Cardiol. 2024;43:525-36
29850
Acesso de texto completo
24477
Cardiovascular benefits of resistance exercise: It's time to prescribeHélder Dores, Mafalda Antunes, Daniel Caldeira, Hugo V. Pereira
Rev Port Cardiol. 2024;43:573-82
24477
Acesso de texto completo
15577
Cardiovascular risk assessment using SCORE2 in a population with hypertension – The reality at a primary health care unitSara Pereira Santos, Sara Guedes, Ricardo Pesqueira, João Stuart, Ana M. Carvalho, Patrícia Correia, Isabel Lourenço Ribeiro, Ângela M. Teixeira
Rev Port Cardiol. 2024;43:601-10
15577
Acesso de texto completo
10124
Pulmonary arterial hypertension: Navigating the pathways of progress in diagnosis, treatment, and patient careMiguel Azaredo Raposo, Daniel Inácio Cazeiro, Tatiana Guimarães, Nuno Lousada, Céline Freitas, Joana Brito, Susana Martins, Catarina Resende, ... Rui Plácido
Rev Port Cardiol. 2024;43:699-719
10124
Acesso de texto completo
9279
Diagnostic prediction rules in acute pulmonary embolism: Is it acceptable to compromise safety?Sílvio Leal
Rev Port Cardiol. 2024;43:561-2
9279
Acesso de texto completo
8906
Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of CardiologyMiguel Nobre Menezes, Marta Tavares da Silva, Andreia Magalhães, Bruno Melica, Júlia Cristina Toste, Rita Calé, Manuel Almeida, Manuela Fiuza, Eduardo Infante de Oliveira
Rev Port Cardiol. 2024;43:35-48
8906
Acesso de texto completo
8804
Effectiveness and safety of non-invasive ventilation in the management of cardiogenic shockLuna Carrillo-Aleman, Angel Andres Agamez-Luengas, Miguel Guia, Ana Renedo-Villarroya, Nuria Alonso-Fernández, Laura Lopez-Gomez, Pablo Bayoumy-Delis, Juan M. Sanchez-Nieto, ... Andrés Carrillo-Alcaraz
Rev Port Cardiol. 2024;43:259-73
8804
Acesso de texto completo
8746
Validation of the SCORE2 risk prediction algorithm in a Portuguese population: A new model to estimate 10-year cardiovascular disease incidence in EuropeMargarida Temtem, Maria Isabel Mendonça, Marina Santos, Débora Sá, Francisco Sousa, Sónia Freitas, Sofia Borges, Eva Henriques, ... Roberto Palma Reis
Rev Port Cardiol. 2024;43:437-44
8746
Acesso de texto completo
8259
Cardiovascular risk assessment in Portugal's primary health care system: SCORE vs. SCORE2Cristina Silva, José Eduardo Mendes, Ricardo Ramos, Amélia Gaspar, Filipe Leal, Nuno Mendes
Rev Port Cardiol. 2024;43:449-55
8259
Acesso de texto completo
7896
Comparison of the accuracy of four diagnostic prediction rules for pulmonary embolism in patients admitted to the emergency departmentBeatriz Valente Silva, Cláudia Jorge, Rui Plácido, Miguel Nobre Menezes, Carlos Mendonça, Maria Luísa Urbano, Joana Rigueira, Ana G. Almeida, Fausto J. Pinto
Rev Port Cardiol. 2024;43:551-9
7896
Acesso de texto completo
7444
Sleep apnea and sudden death in the non-cardiac population: A systematic reviewAlessandra Barboza Resende Martinez, Guilherme Ribeiro Barbosa, Matheus Rodrigues Lopes, Romero Henrique de Almeida Barbosa
Rev Port Cardiol. 2024;43:279-90
7444
Acesso de texto completo
7177
The culprit of uncontrolled hypertension: A case of monoamine oxidase inhibitor and clonidine interactionLinfang Deng, Lihua Shi, Xiaolan Ye
Rev Port Cardiol. 2024;43:223-4
7177
Acesso de texto completo
6296
Left bundle branch block-induced dilated cardiomyopathy: Definitions, pathophysiology, and therapyCatarina Amaral Marques, Ana Laura Costa, Elisabete Martins
Rev Port Cardiol. 2024;43:623-32
6296
Acesso de texto completo
6193
Home- versus centre-based EXercise InTervention in patients with Heart Failure (EXIT-HF trial): A pragmatic randomized controlled trialCristine Schmidt, Sandra Magalhães, Priscilla Gois Basilio, Marisol Gouveia, Manuel Teixeira, Cláudio Santos, Aida Isabel Tavares, João Pedro Ferreira, ... Mário Santos
Rev Port Cardiol. 2024;43:149-58
6193
Acesso de texto completo
6151
Clips on the X-ray: Expect the unexpectedRita Justo Pereira, Mariana Lemos, Isabel Sampaio Graça, Graça Nogueira, Rui Anjos
Rev Port Cardiol. 2024;43:95-6
6151
Acesso de texto completo
6026
World Heart Federation Cholesterol Roadmap: The Portuguese caseAna Abreu, Hélder Dores, Lino Gonçalves, Fátima Franco, Conceição Silveira, Gonçalo Proença, Ana Teresa Timóteo, Nuno Cardim, ... Fausto J. Pinto
Rev Port Cardiol. 2024;43:633-41
6026
Acesso de texto completo
6002
RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the oneRodolfo P. Rothlin, Facundo Pelorosso, Mariano Duarte, Liliana Nicolosi, Ignacio Fernandez Criado, María Victoria Salgado, Héctor Vetulli
Rev Port Cardiol. 2024;43:219-20
6002
Acesso de texto completo
5777
Refining the classification of cardiovascular preventionRui Azevedo Guerreiro
Rev Port Cardiol. 2024;43:159-62
5777
Acesso de texto completo
5684
PrOgnosis in Pulmonary Embolism (PoPE): 30-Day mortality risk score based on five admission parametersFilipa Gerardo, Daniel Faria, Pedro Silvério António, João Baltazar Ferreira, Marco Beringuilho, Hilaryano Ferreira, Inês Fialho, Inês Miranda, ... João B. Augusto
Rev Port Cardiol. 2024;43:1-8
5684
Acesso de texto completo
5538
Loop diuretic discontinuation in chronic heart failure patients: A retrospective studyGonçalo Silva, Brenda Moura, Emília Moreira, Cláudia Camila Dias, Bernardo Sousa Pinto, Manuel Campelo, Sandra Amorim, Elisabete Martins, ... José Silva Cardoso
Rev Port Cardiol. 2024;43:513-22
5538
Acesso de texto completo

